Scpharmaceuticals inc. (SCPH)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17
Operating expenses:
Research and development

22,254

24,632

19,462

19,065

18,424

15,948

16,515

16,204

15,494

14,331

0

0

0

General and administrative

8,453

8,273

8,232

8,181

11,391

13,719

14,637

14,357

11,682

9,105

0

0

0

Total operating expenses

30,707

32,905

27,694

27,246

29,815

29,667

31,152

30,561

27,176

23,436

0

0

0

Loss from operations

-30,707

-32,905

-27,694

-27,246

-29,815

-29,667

-31,152

-30,561

-27,176

-23,436

0

0

0

Other expense

-7

16

63

-25

-22

-56

-65

-45

23

75

0

0

0

Interest income

1,394

1,660

1,842

1,890

1,851

1,712

1,391

1,021

655

341

0

0

0

Interest expense

2,049

1,767

1,492

1,454

1,444

1,432

0

0

0

-

0

0

-

Net loss and comprehensive loss

-31,369

-32,996

-27,281

-26,835

-29,430

-29,443

-31,223

-30,951

-27,637

-23,817

0

0

0

Net loss per share — basic and diluted

-0.35

-0.58

-0.33

-0.39

-0.47

-0.28

-0.31

-0.53

-0.47

7.72

-5.08

-6.09

-4.59

Weighted average common shares outstanding — basic and diluted

20,218

18,662

18,584

18,580

18,575

18,569

18,569

18,549

18,535

8,627

1,080

1,072

1,070